LeonaBio, Inc. Defined Contribution Plan, Cost
LeonaBio, Inc. (LONA) reported Defined Contribution Plan, Cost of $200.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-03-31
- LeonaBio, Inc. defined contribution plan, cost for fiscal 2025 was $200.00K, a 60.00% decline from fiscal 2024.
- LeonaBio, Inc. defined contribution plan, cost for fiscal 2024 was $500.00K, a 0.00% change from fiscal 2023.
- LeonaBio, Inc. defined contribution plan, cost for fiscal 2023 was $500.00K, a 25.00% increase from fiscal 2022.
- LeonaBio, Inc. defined contribution plan, cost for fiscal 2022 was $400.00K.
| Period end | Defined Contribution Plan, Cost 12 month | Defined Contribution Plan, Cost 12 month as first filed |
|---|---|---|
| 2025-12-31 | $200.00K 10-K · filed 2026-03-31 | |
| 2024-12-31 | $500.00K 10-K · filed 2026-03-31 | |
| 2023-12-31 | $500.00K 10-K · filed 2025-02-27 | |
| 2022-12-31 | $400.00K 10-K · filed 2024-02-22 | $354.00K 10-K · filed 2023-03-23 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-23 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-28 | |
| 2019-12-31 | $0.00 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |